Treatment for advanced poorly differentiated neuroendocrine carcinoma should parallel treatments used for small-cell lung cancer.
2
病人和方法：符合这次多中心二期实验的病人患有转移性低分化神经内分泌癌，并且之前未接受任何治疗。
Patients and METHODS: Patients eligible for this multicenter, phase II trial had metastatic poorly differentiated neuroendocrine carcinoma and had received no previous treatment.
点击反馈